Ovarian Carcinoma: Etiology, Diagnosis, and Treatment
Autor Hugh R. K. Barber Cuvânt înainte de F. Rutledgeen Limba Engleză Paperback – 9 noi 2011
Preț: 370.84 lei
Preț vechi: 390.36 lei
-5% Nou
Puncte Express: 556
Preț estimativ în valută:
70.97€ • 73.72$ • 58.95£
70.97€ • 73.72$ • 58.95£
Carte tipărită la comandă
Livrare economică 03-17 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781461392347
ISBN-10: 1461392349
Pagini: 380
Ilustrații: XIV, 362 p.
Dimensiuni: 178 x 254 x 20 mm
Greutate: 0.66 kg
Ediția:3rd ed. 1993. Softcover reprint of the original 3rd ed. 1993
Editura: Springer
Colecția Springer
Locul publicării:New York, NY, United States
ISBN-10: 1461392349
Pagini: 380
Ilustrații: XIV, 362 p.
Dimensiuni: 178 x 254 x 20 mm
Greutate: 0.66 kg
Ediția:3rd ed. 1993. Softcover reprint of the original 3rd ed. 1993
Editura: Springer
Colecția Springer
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
1 Introduction.- 2 Anatomy, Embryology, and Comparative Anatomy.- 3 Epidemiology of Cancer of the Ovary.- 4 Histologic Classification of Ovarian Tumors.- 5 Histologic Typing of Ovarian Tumors: Definitions and Discussion.- 6 Histologic, Nuclear, and Stromal Grading.- 7 Symptoms, Signs, and Diagnosis.- 8 Diagnostic Evaluation and Preoperative Work-up.- 9 Preoperative and Postoperative Management.- 10 Diagnosing and Managing the Adnexal Mass.- 11 Staging Ovarian Cancer.- 12 Treatment of the Common Epithelial Cancers.- 13 Managing Ovarian Tumors of Childhood and Adolescence.- 14 Ovarian Cancer Complicating Pregnancy.- 15 Low Malignant Potential Ovarian Tumors: Borderline Ovarian Tumors.- 16 Postmenopausal Palpable Ovary Syndrome.- 17 Surgical Treatment of Cancer of the Ovary: Technique.- 18 Recurrent Cancer of the Ovary: Surgical Treatment.- 19 Second Look Operation.- 20 Role of Radioactive Isotopes in Management of Ovarian Cancer.- 21 Role of Chemotherapy in Ovarian Cancer.- 22 Platinum Drugs.- 23 Role of Radiation Therapy in Management of Ovarian Cancer.- 24 Autoimmune and Immunodeficiency Diseases.- 25 Tumor Markers in Ovarian Cancer.- 26 Sex Steriod Receptors.- 27 Biologic Response Modification.- 28 Immunotherapy and Immunopotentiation.- 29 Directions in the Design of Clinical Trials, Present and Future.- Addendum.